Hakutulokset - Martin Guillot

Nonclinical cardiovascular safety evaluation of romosozumab, an inhibitor of sclerostin for the treatment of osteoporosis in postmenopausal women at high risk of fracture Tekijä James R. Turk, Aimée M. Deaton, Jun Yin, Marina Stolina, Melanie Felx, Gabrielle Boyd, Jean-Guy Bienvenu, Aurore Varela, Martin Guillot, Gill Holdsworth, Alison Wolfreys, Denise Dwyer, Sheetal Kumar, Emily M. de Koning, Yusheng Qu, Michael J. Engwall, Kathrin Locher, Lucas D. Ward, Charles Glaus, Yudong D. He, Rogely Boyce

Hae kokoteksti